CLINICAL_TRIALS
withdrawal
· 2017-04-28
Clinical Trial Update: The Utility of NIOM During LITT for Refractory MTLE [NA]
Summary
The clinical trial NCT02913742 exploring NIOM during LITT for refractory mesial temporal lobe epilepsy has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Duke University | Conditions: Epilepsy, Temporal Lobe | NA | Status: WITHDRAWN